Tech24 Deals Web Search

Search results

1. Results from the Tech24 Deals Content Network

2. Orlistat - Wikipedia

   en.wikipedia.org/wiki/Orlistat

   Orlistat, sold under the brand name Xenical among others, is a medication used to treat obesity. Its primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby reducing caloric intake. It is intended for use in conjunction with a healthcare provider-supervised reduced-calorie diet.

3. Steatorrhea - Wikipedia

   en.wikipedia.org/wiki/Steatorrhea

   Steatorrhea. Specialty. Gastroenterology, general surgery. Steatorrhea (or steatorrhoea) is the presence of excess fat in feces. Stools may be bulky and difficult to flush, have a pale and oily appearance, and can be especially foul-smelling. [ 1] An oily anal leakage or some level of fecal incontinence may occur.

4. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   e. Orlistat (Xenical), the most commonly used medication to treat obesity and sibutramine (Meridia), a medication that was withdrawn due to cardiovascular side effects. Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control excess body fat. These medications alter one of the fundamental processes of ...

5. Pfizer drops twice-daily version of obesity pill over side ...

   www.aol.com/news/pfizer-pulls-plug-twice-daily...

   Pfizer has a once-daily version of the weight-loss pill still in the development. It hopes a change in the drug's release mechanism can reduce side effects, but early data on the new formulation ...

6. Pfizer's twice-daily weight-loss pill discontinued due to ...

   www.aol.com/news/ozempic-without-injection...

   Pfizer announced on Dec. 1 that it was discontinuing phase 3 clinical trials of the twice-daily version due to high rates of adverse side effects. While these were mostly mild, a large percentage ...

7. Lilly says weight loss drug cuts heart failure risk by ... - AOL

   www.aol.com/news/lilly-says-weight-loss-drug...

   The drug led to 15.7% weight loss in the combined population of people with and without type 2 diabetes, compared with 2.2% for the placebo, Lilly said. For the non-diabetes patients, weight loss ...